Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viñals

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 24, 2023
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institutionFelipe A Calvo, Jacobo Palma, Javier Serrano, et al.
Journal of Materials Chemistry. B|October 23, 2024
Iodine-substituted hydroxyapatite nanoparticles and activation of derived ceramics for range verification in proton therapyR Magro Hernández, A Muñoz-Noval, J A Briz, et al.
EMBO Molecular Medicine|May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitorsÁlvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 22, 2022
Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocolEsther Dechantsreiter, Frank Padberg, Alon Morash, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Nature Metabolism|January 30, 2026
Glucose deprivation drives LIF-dependent lung cancerFedra Luciano-Mateo, Joaquim Moreno-Caceres, Miguel Hernández-Madrigal, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton TherapyMarta Ibáñez-Moragues, Irene Fernández-Barahona, Rocío Santacruz, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 24, 2023
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institutionFelipe A Calvo, Jacobo Palma, Javier Serrano, et al.
Journal of Materials Chemistry. B|October 23, 2024
Iodine-substituted hydroxyapatite nanoparticles and activation of derived ceramics for range verification in proton therapyR Magro Hernández, A Muñoz-Noval, J A Briz, et al.
EMBO Molecular Medicine|May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitorsÁlvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 22, 2022
Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocolEsther Dechantsreiter, Frank Padberg, Alon Morash, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Nature Metabolism|January 30, 2026
Glucose deprivation drives LIF-dependent lung cancerFedra Luciano-Mateo, Joaquim Moreno-Caceres, Miguel Hernández-Madrigal, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton TherapyMarta Ibáñez-Moragues, Irene Fernández-Barahona, Rocío Santacruz, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
EMBO Molecular Medicine|June 19, 2013
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancerDiana Cepeda, Hwee-Fang Ng, Hamid Reza Sharifi, et al.
Pageof 38